¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Drug caution codes"¿¡ ´ëÇÑ °æºÏ´ëÇб³ Ä¡°ú´ëÇÐ ±¸°³»°úÇб³½Ç »çÀü ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
¼³¸í
drug industry
¾à¹° Á¦¾à °ø¾÷
drug interference
¾à¹° °£¼·
drug metabolism
¾à¹° ´ë»ç
drug misuse
¾à¹° ¿À¿ë
¾à¹°À» ºÎÀûÇÕÇÏ°Ô »ç¿ëÇÏ¿© »ý±â´Â Áõ»óÀ¸·Î ¾à¹° ³²¿ë
drug of choice
¼±Åà ¾àÁ¦, Ưȿ ¾à
drug overload
¾à¹° °ú·® º¹¿ë
drug potentialization
¾à¹° »ó½Â, ¾à¹° »ó½Â ÀÛ¿ë
drug prophylaxis
¾àÁ¦ ¿¹¹æ
drug rash
¾à¹°¼º ¹ßÁø, ¾àÁø
drug receptor
¾à¹° ¼ö¿ëü
drug resistance factor
¾àÁ¦ ³»¼º ÀÎÀÚ
drug resistance transfer factor
¾àÁ¦ ³»¼º Àü´Þ ÀÎÀÚ
drug shock
¾à¹° Ãæ°Ý
drug side effect
ºÎÀÛ¿ë
drug therapy
¾à¹° º¹¿ë
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½